Program Development Officer (Drugs for Rare Diseases) – 2 positions
CDA-AMC
About this role
A Program Development Officer at Canada's Drug Agency (CDA-AMC) focuses on developing and defining deliverables for projects related to emerging opportunities in health and health policy, particularly in the area of drugs for rare diseases. The role involves working with internal teams to meet health care decision-maker needs, balancing customer needs with project feasibility, and representing the organization nationally and internationally.
Skills
Qualifications
About CDA-AMC
cda-amc.caThe Canadian Dental Association (CDA / Association dentaire canadienne) is the national voice for dentistry in Canada, representing dentists and promoting oral health. It provides clinical guidance, practice-management tools, continuing professional development, evidence-based resources and policy advocacy to support dental professionals. CDA publishes the Journal of the Canadian Dental Association and offers public-facing information on oral health, finding a dentist, and dental benefits. The organization also collaborates with governments, researchers and stakeholders to advance oral health policy, standards of care, and research.
About CDA-AMC
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for CDA-AMC.
Salary
$88k – $109k
per year
More jobs at CDA-AMC
Similar Jobs
Rare Diseases Registries Head
Sanofi
Public Affairs Lead Rare Diseases
Ipsen
Medical Manager Rare Diseases – Balkans
American Association of Physicists in Medicine
Key Account Manager Rare Diseases - Cluj
American Association of Physicists in Medicine
Commercial Lead Slovenia & Croatia, Rare Diseases
Digital Biology
Director, Market Access (Rare Diseases)
Regeneron Pharmaceuticals